Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Twist Bioscience CorpTWST · Entity 3619 | See Remark | May 03, 2024 | May 07, 2024 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Twist Bioscience Corp
Report date May 03, 2024 · Filed May 07, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 345,188 |
Reported balance
After 2024-05-03 transaction · row 1
1 source rowRow 1 · 2024-05-03 · Sale · Disposed 798 · Balance 345,188 F1: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 18, 2022 Filed Feb 23, 2022 23:03 UTC | Twist Bioscience Corp TWST · Entity 3619 | Tax withholdingCommon Stock | 670 | $53.21 | $35,650.70 |
DisclosureSEC source: 0001214659-22-003109 · marketforms-55520.xml · nonDerivative · entry 1 Banyai William · CIK 0001753670 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 264,353 F1 · shares: Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units ("RSUs") previously granted to the Reporting Person. Such withholding is exempt from Section 16(b) pursuant to Rule 16b-3(e). Read SEC document |
| January 28, 2022 Filed Feb 1, 2022 21:35 UTC | Twist Bioscience Corp TWST · Entity 3619 | Tax withholdingCommon Stock | 151 | $77.39 | $11,685.89 |
DisclosureSEC source: 0001214659-22-001590 · marketforms-55184.xml · nonDerivative · entry 1 Banyai William · CIK 0001753670 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 265,023 F1 · shares: Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units ("RSUs") previously granted to the Reporting Person. Such withholding is exempt from Section 16(b) pursuant to Rule 16b-3(e). Read SEC document |
| January 25, 2022 Filed Jan 26, 2022 21:35 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 348 | $54.73 | $19,046.04 |
DisclosureSEC source: 0001214659-22-001142 · marketforms-55138.xml · nonDerivative · entry 2 Banyai William · CIK 0001753670 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 265,174 F2 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on September 15, 2021 Read SEC document |
| January 24, 2022 Filed Jan 26, 2022 21:35 UTC | Twist Bioscience Corp TWST · Entity 3619 | Tax withholdingCommon Stock | 231 | $55.87 | $12,905.97 |
DisclosureSEC source: 0001214659-22-001142 · marketforms-55138.xml · nonDerivative · entry 1 Banyai William · CIK 0001753670 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 265,522 F1 · shares: Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units ("RSUs") previously granted to the Reporting Person. Such withholding is exempt from Section 16(b) pursuant to Rule 16b-3(e). Read SEC document |
| January 21, 2022 Filed Jan 25, 2022 21:35 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 245 | $53.36 | $13,073.20 |
DisclosureSEC source: 0001214659-22-001099 · marketforms-55130.xml · nonDerivative · entry 1 Banyai William · CIK 0001753670 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 265,753 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on September 15, 2021. Read SEC document |
| January 04, 2022 Filed Jan 5, 2022 21:35 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 292 | $83.49 | $24,379.08 |
DisclosureSEC source: 0001214659-22-000329 · marketforms-54929.xml · nonDerivative · entry 2 Banyai William · CIK 0001753670 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 265,998 F2 · shares: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on August 28, 2020 Read SEC document |
| January 03, 2022 Filed Jan 5, 2022 21:35 UTC | Twist Bioscience Corp TWST · Entity 3619 | Tax withholdingCommon Stock | 195 | $77.39 | $15,091.05 |
DisclosureSEC source: 0001214659-22-000329 · marketforms-54929.xml · nonDerivative · entry 1 Banyai William · CIK 0001753670 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 266,290 F1 · shares: Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units ("RSUs") previously granted to the Reporting Person. Such withholding is exempt from Section 16(b) pursuant to Rule 16b-3(e). Read SEC document |
| December 27, 2021 Filed Dec 29, 2021 21:35 UTC | Twist Bioscience Corp TWST · Entity 3619 | GrantCommon Stock | 6,057 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-21-013758 · marketforms-54800.xml · nonDerivative · entry 1 Banyai William · CIK 0001753670 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 266,485 F1 · shares: Represents a restricted stock unit award ("RSU") of which 1/16th of the total number of RSUs vest on each quarterly anniversary of October 1, 2021, for a total vesting period of 48 months, subject to the Reporting Person's continuous service through each vesting date. Read SEC document |
| December 15, 2021 Filed Dec 17, 2021 21:35 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 1,010 | $89.50 | $90,392.58 |
DisclosureSEC source: 0001214659-21-013350 · marketforms-54655.xml · nonDerivative · entry 7 Banyai William · CIK 0001753670 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 260,428 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on August 28, 2020. F8 · shares: Represents the weighted average sales price per share. The shares sold at prices ranging from $89.34 to $89.72 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
| December 15, 2021 Filed Dec 17, 2021 21:35 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 2,439 | $88.88 | $216,787.10 |
DisclosureSEC source: 0001214659-21-013350 · marketforms-54655.xml · nonDerivative · entry 6 Banyai William · CIK 0001753670 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 261,438 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on August 28, 2020. F7 · shares: Represents the weighted average sales price per share. The shares sold at prices ranging from $88.34 to $89.32 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
| December 15, 2021 Filed Dec 17, 2021 21:35 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 506 | $87.57 | $44,309.66 |
DisclosureSEC source: 0001214659-21-013350 · marketforms-54655.xml · nonDerivative · entry 5 Banyai William · CIK 0001753670 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 263,877 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on August 28, 2020. F6 · shares: Represents the weighted average sales price per share. The shares sold at prices ranging from $87.29 to $88.03 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
| December 15, 2021 Filed Dec 17, 2021 21:35 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 1,206 | $86.30 | $104,081.42 |
DisclosureSEC source: 0001214659-21-013350 · marketforms-54655.xml · nonDerivative · entry 4 Banyai William · CIK 0001753670 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 264,383 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on August 28, 2020. F5 · shares: Represents the weighted average sales price per share. The shares sold at prices ranging from $85.90 to $86.87 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
| December 15, 2021 Filed Dec 17, 2021 21:35 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 4,370 | $85.29 | $372,715.99 |
DisclosureSEC source: 0001214659-21-013350 · marketforms-54655.xml · nonDerivative · entry 3 Banyai William · CIK 0001753670 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 265,589 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on August 28, 2020. F4 · shares: Represents the weighted average sales price per share. The shares sold at prices ranging from $84.90 to $85.89 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
| December 15, 2021 Filed Dec 17, 2021 21:35 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 11,769 | $84.36 | $992,870.50 |
DisclosureSEC source: 0001214659-21-013350 · marketforms-54655.xml · nonDerivative · entry 2 Banyai William · CIK 0001753670 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 269,959 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on August 28, 2020. F3 · shares: Represents the weighted average sales price per share. The shares sold at prices ranging from $83.86 to $84.85 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
| December 15, 2021 Filed Dec 17, 2021 21:35 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 3,700 | $83.50 | $308,939.64 |
DisclosureSEC source: 0001214659-21-013350 · marketforms-54655.xml · nonDerivative · entry 1 Banyai William · CIK 0001753670 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 281,728 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on August 28, 2020. F2 · shares: Represents the weighted average sales price per share. The shares sold at prices ranging from $82.855 to $83.84 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
| November 22, 2021 Filed Nov 23, 2021 21:36 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 2,431 | $104.92 | $255,067.08 |
DisclosureSEC source: 0001214659-21-012191 · marketforms-54355.xml · nonDerivative · entry 9 Banyai William · CIK 0001753670 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 285,428 F2 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on August 28, 2020. F10 · shares: Represents the weighted average sales price per share. The shares sold at prices ranging from $104.56 to $105.26 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
| November 22, 2021 Filed Nov 23, 2021 21:36 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 1,967 | $103.78 | $204,142.14 |
DisclosureSEC source: 0001214659-21-012191 · marketforms-54355.xml · nonDerivative · entry 8 Banyai William · CIK 0001753670 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 287,859 F2 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on August 28, 2020. F9 · shares: Represents the weighted average sales price per share. The shares sold at prices ranging from $103.40 to $104.37 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
| November 22, 2021 Filed Nov 23, 2021 21:36 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 3,900 | $102.86 | $401,135.28 |
DisclosureSEC source: 0001214659-21-012191 · marketforms-54355.xml · nonDerivative · entry 7 Banyai William · CIK 0001753670 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 289,826 F2 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on August 28, 2020. F8 · shares: Represents the weighted average sales price per share. The shares sold at prices ranging from $102.39 to $103.37 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
| November 22, 2021 Filed Nov 23, 2021 21:36 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 3,926 | $101.81 | $399,693.89 |
DisclosureSEC source: 0001214659-21-012191 · marketforms-54355.xml · nonDerivative · entry 6 Banyai William · CIK 0001753670 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 293,726 F2 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on August 28, 2020. F7 · shares: Represents the weighted average sales price per share. The shares sold at prices ranging from $101.36 to $102.21 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
| November 22, 2021 Filed Nov 23, 2021 21:36 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 3,966 | $100.66 | $399,236.60 |
DisclosureSEC source: 0001214659-21-012191 · marketforms-54355.xml · nonDerivative · entry 5 Banyai William · CIK 0001753670 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 297,652 F2 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on August 28, 2020. F6 · shares: Represents the weighted average sales price per share. The shares sold at prices ranging from $100.24 to $101.05 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
| November 22, 2021 Filed Nov 23, 2021 21:36 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 1,892 | $99.73 | $188,692.75 |
DisclosureSEC source: 0001214659-21-012191 · marketforms-54355.xml · nonDerivative · entry 4 Banyai William · CIK 0001753670 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 301,618 F2 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on August 28, 2020. F5 · shares: Represents the weighted average sales price per share. The shares sold at prices ranging from $99.14 to $100.025 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
| November 22, 2021 Filed Nov 23, 2021 21:36 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 1,601 | $98.55 | $157,779.67 |
DisclosureSEC source: 0001214659-21-012191 · marketforms-54355.xml · nonDerivative · entry 3 Banyai William · CIK 0001753670 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 303,510 F2 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on August 28, 2020. F4 · shares: Represents the weighted average sales price per share. The shares sold at prices ranging from $98.07 to $98.99 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
| November 22, 2021 Filed Nov 23, 2021 21:36 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 300 | $96.97 | $29,091.00 |
DisclosureSEC source: 0001214659-21-012191 · marketforms-54355.xml · nonDerivative · entry 2 Banyai William · CIK 0001753670 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 305,111 F2 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on August 28, 2020. F3 · shares: Represents the weighted average sales price per share. The shares sold at prices ranging from $96.62 to $97.15 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
| November 19, 2021 Filed Nov 23, 2021 21:36 UTC | Twist Bioscience Corp TWST · Entity 3619 | Tax withholdingCommon Stock | 967 | $110.62 | $106,969.54 |
DisclosureSEC source: 0001214659-21-012191 · marketforms-54355.xml · nonDerivative · entry 1 Banyai William · CIK 0001753670 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 305,411 F1 · shares: Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units ("RSUs") previously granted to the Reporting Person. Such withholding is exempt from Section 16(b) pursuant to Rule 16b-3(e). Read SEC document |
| October 25, 2021 Filed Oct 26, 2021 23:10 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 9,974 | $118.68 | $1,183,676.42 |
DisclosureSEC source: 0001214659-21-010773 · ownership.xml · nonDerivative · entry 5 Banyai William · CIK 0001753670 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 306,378 F2 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on August 28, 2020. F6 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $118.44 to $118.94 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
| October 25, 2021 Filed Oct 26, 2021 23:10 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 7,619 | $117.96 | $898,741.05 |
DisclosureSEC source: 0001214659-21-010773 · ownership.xml · nonDerivative · entry 4 Banyai William · CIK 0001753670 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 316,352 F2 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on August 28, 2020. F5 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $117.44 to $118.43 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
| October 25, 2021 Filed Oct 26, 2021 23:10 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 863 | $117.13 | $101,083.19 |
DisclosureSEC source: 0001214659-21-010773 · ownership.xml · nonDerivative · entry 3 Banyai William · CIK 0001753670 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 323,971 F2 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on August 28, 2020. F4 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $116.44 to $117.40 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
| October 25, 2021 Filed Oct 26, 2021 23:10 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 1,335 | $115.79 | $154,579.12 |
DisclosureSEC source: 0001214659-21-010773 · ownership.xml · nonDerivative · entry 2 Banyai William · CIK 0001753670 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 324,834 F2 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on August 28, 2020. F3 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $115.37 to $116.30 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
| October 22, 2021 Filed Oct 26, 2021 23:10 UTC | Twist Bioscience Corp TWST · Entity 3619 | Tax withholdingCommon Stock | 288 | $117.41 | $33,814.08 |
DisclosureSEC source: 0001214659-21-010773 · ownership.xml · nonDerivative · entry 1 Banyai William · CIK 0001753670 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 326,169 F1 · shares: Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units ("RSUs") previously granted to the Reporting Person. Such withholding is exempt from Section 16(b) pursuant to Rule 16b-3(e). Read SEC document |
| October 13, 2021 Filed Oct 15, 2021 20:35 UTC | Twist Bioscience Corp TWST · Entity 3619 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 11,348 | $0.00 Strike: $8.82 | $0.00 |
DisclosureSEC source: 0001214659-21-010533 · marketforms-54016.xml · derivative · entry 4 Banyai William · CIK 0001753670 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 141,161 Underlying: Common Stock · 11,348 shares Expires 2027-09-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option is immediately exercisable. 10% of the shares subject to the option vested on September 28, 2017, 15% of the shares subject to the option vested on September 28, 2018, and1/48th of the shares subject to the option vest on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date. Read SEC document |
| October 13, 2021 Filed Oct 15, 2021 20:35 UTC | Twist Bioscience Corp TWST · Entity 3619 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 16,833 | $0.00 Strike: $5.95 | $0.00 |
DisclosureSEC source: 0001214659-21-010533 · marketforms-54016.xml · derivative · entry 3 Banyai William · CIK 0001753670 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,166 Underlying: Common Stock · 16,833 shares Expires 2025-09-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The option is immediately exercisable. 25% of the shares subject to the option vested on September 1, 2016 and 1/48th of the shares subject to the option vest on each monthly anniversarythereafter, subject to the Reporting Person's continuous service through each vesting date. Read SEC document |
| October 13, 2021 Filed Oct 15, 2021 20:35 UTC | Twist Bioscience Corp TWST · Entity 3619 | Exercise / conversionCommon Stock | 11,348 | $8.82 | $100,089.36 |
DisclosureSEC source: 0001214659-21-010533 · marketforms-54016.xml · nonDerivative · entry 2 Banyai William · CIK 0001753670 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 326,457 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 13, 2021 Filed Oct 15, 2021 20:35 UTC | Twist Bioscience Corp TWST · Entity 3619 | Exercise / conversionCommon Stock | 16,833 | $5.95 | $100,156.35 |
DisclosureSEC source: 0001214659-21-010533 · marketforms-54016.xml · nonDerivative · entry 1 Banyai William · CIK 0001753670 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 315,109 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 04, 2021 Filed Oct 6, 2021 20:40 UTC | Twist Bioscience Corp TWST · Entity 3619 | Tax withholdingCommon Stock | 242 | $105.50 | $25,531.00 |
DisclosureSEC source: 0001214659-21-010290 · marketforms-53983.xml · nonDerivative · entry 1 Banyai William · CIK 0001753670 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 298,276 F1 · shares: Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units ("RSUs") previously granted to the Reporting Person. Such withholding is exempt from Section 16(b) pursuant to Rule 16b-3(e). Read SEC document |
| September 20, 2021 Filed Sep 22, 2021 20:35 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 200 | $117.24 | $23,447.00 |
DisclosureSEC source: 0001214659-21-009723 · marketforms-53869.xml · nonDerivative · entry 6 Banyai William · CIK 0001753670 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 298,518 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on August 28, 2020. F7 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $117.23 to $117.24 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
| September 20, 2021 Filed Sep 22, 2021 20:35 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 758 | $116.82 | $88,549.26 |
DisclosureSEC source: 0001214659-21-009723 · marketforms-53869.xml · nonDerivative · entry 5 Banyai William · CIK 0001753670 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 298,718 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on August 28, 2020. F6 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $116.21 to $117.18 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
| September 20, 2021 Filed Sep 22, 2021 20:35 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 1,499 | $115.58 | $173,258.17 |
DisclosureSEC source: 0001214659-21-009723 · marketforms-53869.xml · nonDerivative · entry 4 Banyai William · CIK 0001753670 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 299,476 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on August 28, 2020. F5 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $115.20 to $116.15 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
| September 20, 2021 Filed Sep 22, 2021 20:35 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 4,473 | $114.41 | $511,747.88 |
DisclosureSEC source: 0001214659-21-009723 · marketforms-53869.xml · nonDerivative · entry 3 Banyai William · CIK 0001753670 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 300,975 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on August 28, 2020. F4 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $114.05 to $115.00 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
| September 20, 2021 Filed Sep 22, 2021 20:35 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 9,670 | $113.55 | $1,098,071.05 |
DisclosureSEC source: 0001214659-21-009723 · marketforms-53869.xml · nonDerivative · entry 2 Banyai William · CIK 0001753670 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 305,448 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on August 28, 2020. F3 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $113.05 to $114.04 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
| September 20, 2021 Filed Sep 22, 2021 20:35 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 3,400 | $112.66 | $383,044.34 |
DisclosureSEC source: 0001214659-21-009723 · marketforms-53869.xml · nonDerivative · entry 1 Banyai William · CIK 0001753670 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 315,118 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on August 28, 2020. F2 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $112.05 to $113.03 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
| August 23, 2021 Filed Aug 25, 2021 20:30 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 1,652 | $108.09 | $178,567.82 |
DisclosureSEC source: 0001214659-21-008995 · marketforms-53645.xml · nonDerivative · entry 7 Banyai William · CIK 0001753670 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 318,518 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on August 28, 2020. F8 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $107.72 to $108.45 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
| August 23, 2021 Filed Aug 25, 2021 20:30 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 1,710 | $106.92 | $182,834.40 |
DisclosureSEC source: 0001214659-21-008995 · marketforms-53645.xml · nonDerivative · entry 6 Banyai William · CIK 0001753670 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 320,170 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on August 28, 2020. F7 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $106.61 to $107.59 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
| August 23, 2021 Filed Aug 25, 2021 20:30 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 7,151 | $106.10 | $758,751.13 |
DisclosureSEC source: 0001214659-21-008995 · marketforms-53645.xml · nonDerivative · entry 5 Banyai William · CIK 0001753670 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 321,880 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on August 28, 2020. F6 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $105.61 to $106.59 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
| August 23, 2021 Filed Aug 25, 2021 20:30 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 6,228 | $105.20 | $655,182.49 |
DisclosureSEC source: 0001214659-21-008995 · marketforms-53645.xml · nonDerivative · entry 4 Banyai William · CIK 0001753670 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 329,031 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on August 28, 2020. F5 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $104.61 to $105.59 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
| August 23, 2021 Filed Aug 25, 2021 20:30 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 1,159 | $104.24 | $120,809.99 |
DisclosureSEC source: 0001214659-21-008995 · marketforms-53645.xml · nonDerivative · entry 3 Banyai William · CIK 0001753670 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 335,259 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on August 28, 2020. F4 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $103.60 to $104.53 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
| August 23, 2021 Filed Aug 25, 2021 20:30 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 600 | $102.95 | $61,767.00 |
DisclosureSEC source: 0001214659-21-008995 · marketforms-53645.xml · nonDerivative · entry 2 Banyai William · CIK 0001753670 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 336,418 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on August 28, 2020. F3 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $102.59 to $103.35 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
| August 23, 2021 Filed Aug 25, 2021 20:30 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 1,554 | $101.72 | $158,068.84 |
DisclosureSEC source: 0001214659-21-008995 · marketforms-53645.xml · nonDerivative · entry 1 Banyai William · CIK 0001753670 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 337,018 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on August 28, 2020. F2 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $101.59 to $102.21 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
| August 20, 2021 Filed Aug 24, 2021 20:31 UTC | Twist Bioscience Corp TWST · Entity 3619 | Tax withholdingCommon Stock | 896 | $100.49 | $90,039.04 |
DisclosureSEC source: 0001214659-21-008953 · marketforms-53637.xml · nonDerivative · entry 1 Banyai William · CIK 0001753670 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 338,572 F1 · shares: Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units ("RSUs") previously granted to the Reporting Person. Such withholding is exempt from Section 16(b) pursuant to Rule 16b-3(e). Read SEC document |
| July 26, 2021 Filed Jul 28, 2021 20:30 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 1,258 | $117.49 | $147,797.51 |
DisclosureSEC source: 0001214659-21-007892 · marketforms-53475.xml · nonDerivative · entry 4 Banyai William · CIK 0001753670 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 339,468 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on August 28, 2020. F5 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $117.15 to $117.91 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
| July 26, 2021 Filed Jul 28, 2021 20:30 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 2,195 | $116.69 | $256,135.65 |
DisclosureSEC source: 0001214659-21-007892 · marketforms-53475.xml · nonDerivative · entry 3 Banyai William · CIK 0001753670 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 340,726 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on August 28, 2020. F4 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $116.15 to $117.07 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.